Moroccan Billionaire Expands Business Horizons
Renowned Moroccan billionaire Anas Sefrioui is making significant strides into the pharmaceutical sector with a strategic move to acquire the Moroccan divisions of Servier, which stands as France's second-largest pharmaceutical group. This ambitious expansion marks a notable shift from his established ventures in real estate and cement production, showcasing Sefrioui's adaptability and vision for growth in diverse industries.
Sefrioui's company, Pharma Capital, is seeking to gain full ownership of both Servier Maroc and Servier Maroc Investissements. This proposed acquisition encompasses the entirety of the share capital and voting rights of these subsidiaries, although it remains contingent upon approval from Morocco's Competition Council. Details regarding the purchase price have not been disclosed, but reports indicate that Pharma Capital has outbid several competitors for this lucrative opportunity.
The scope of the transaction extends beyond mere ownership; it includes plans for the production of Servier's medicinal products under license for a period of 15 years. This move not only illustrates Sefrioui's strategic foresight but also highlights his commitment to enhancing the pharmaceutical landscape in Morocco. Prior to this, he had already begun establishing his presence in the pharmaceutical industry through significant stakes in companies such as Afric-Phar, Pharmis, and Partner Lab.
As Sefrioui continues to diversify his portfolio, his transition from real estate mogul to pharmaceutical entrepreneur reflects a broader trend among business leaders seeking to capitalize on the growing demand for healthcare solutions in Africa. The Servier deal represents a pivotal moment in his career, aligning with his vision to not only broaden his business interests but also contribute to the health and wellness of the Moroccan populace.
As reported by africa.businessinsider.com.
